Emily S. Ruiz, MD, FAAD
SESSIONS
F005 Skin Disease in Transplant Recipients and Immunosuppressed Patients
Mar 19, 2027
•
9:00 AM - 11:00 AM
DISCLOSURES
Almirall – Consultant (1099 relationship)(Fees); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Checkpoint Therapeutics – Consultant (1099 relationship)(Fees); Feldan Therapeutics – Consultant (1099 relationship)(Fees); Merck – Investigator(Grants/Research Funding); Regeneron – Advisory Board(Fees), Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees), Consultant (1099 relationship)(Fees);